Wyoming Tech Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Wyoming Tech Reporter.

Press releases published on June 22, 2026

6 hours ago

Rezolve Ai Powers New Mashreq and Visa Everyday Cashback Program, Bringing AI-Enabled Card Linked Offers to UAE Cardholders

Indeterminate GlobeNewswire

6 hours ago

Genius Group Buys Back 6,037,851 Company Shares

Indeterminate GlobeNewswire

6 hours ago

Quantum Cyber Issues Letter to Shareholders

Indeterminate GlobeNewswire

6 hours ago

BridgeBio to Present Primary Results from Phase 3 PROPEL 3 Trial of Oral Infigratinib for Children Living with Achondroplasia at ICCBH 2026

Indeterminate GlobeNewswire

6 hours ago

Medicus Pharma to Showcase SkinJect® Registrational Strategy and Teverelix® Precision Medicine Program at Bio International 2026

Indeterminate GlobeNewswire

6 hours ago

Nuvectis Announces Strategic Portfolio Expansion via License Agreement for Ex-China Rights with Haisco Pharmaceutical Group for Two Potentially Best-In Class Clinical-Stage Compounds

Indeterminate GlobeNewswire

7 hours ago

TScan Therapeutics Announces Positive Initial Data from Cohort C of Ongoing ALLOHA™ Phase 1 Study Evaluating TSC-101 in Patients with Heme Malignancies Undergoing Allogeneic Hematopoietic Cell Transplantation

Indeterminate GlobeNewswire

7 hours ago

Cemdisiran Regulatory Submissions Accepted for Review by FDA and EMA for the Treatment of Generalized Myasthenia Gravis (gMG)

Indeterminate GlobeNewswire

7 hours ago

NRx Pharmaceuticals Announces FDA Grant of Expanded Access Protocol for Use of D-Cycloserine-based NRX-101 for Augmentation of Transcranial Magnetic Stimulation in the Treatment of Depression

Indeterminate GlobeNewswire

7 hours ago

WTOP News Names HRCI A Winner Of The Greater Washington Area Top Workplaces 2026 Award

Indeterminate GlobeNewswire

7 hours ago

MapLight Announces Topline Results from Phase 2 IRIS Study for ML-004 in Autism Spectrum Disorder

Indeterminate GlobeNewswire

7 hours ago

Eledon Presents Long-Term Extension Phase 2 BESTOW Results at American Transplant Congress Showing Sustained Higher Kidney Function and Improved Patient-Reported Outcomes with Tegoprubart Compared with Tacrolimus

Indeterminate GlobeNewswire

7 hours ago

Seer and Korea University Present Preliminary Data at ASMS 2026 Demonstrating Potential of AI-Driven Plasma Proteomics for Multi-Cancer Screening

Indeterminate GlobeNewswire

7 hours ago

Ligand Announces Proposed Offering of $550 Million of Convertible Senior Notes Due 2031

Indeterminate GlobeNewswire

7 hours ago

Digital Realty Announces Transactions to Drive Continued Platform Growth

Indeterminate GlobeNewswire

7 hours ago

Can-Fite Publishes Peer-Reviewed Scientific Article Demonstrating the Broad Therapeutic Potential of Piclidenoson and Namodenoson

Indeterminate GlobeNewswire

7 hours ago

QTREX Announces Management Share Purchase Plan

Indeterminate GlobeNewswire

7 hours ago

Mavenir Launches Agentic Service Assurance Framework to Monitor and Operate the Network

Indeterminate GlobeNewswire

8 hours ago

Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Indeterminate GlobeNewswire

8 hours ago

Nura Bio Completes $73.8M Series B Financing and Advances Pipeline of SARM1 Inhibitors

Indeterminate GlobeNewswire